400 related articles for article (PubMed ID: 28110971)
1. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.
Frontera JA; Starling R; Cho SM; Nowacki AS; Uchino K; Hussain MS; Mountis M; Moazami N
J Heart Lung Transplant; 2017 Jun; 36(6):673-683. PubMed ID: 28110971
[TBL] [Abstract][Full Text] [Related]
2. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
Cho SM; Moazami N; Frontera JA
Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular Accidents During Mechanical Circulatory Support: New Predictors of Ischemic and Hemorrhagic Strokes and Outcome.
Izzy S; Rubin DB; Ahmed FS; Akbik F; Renault S; Sylvester KW; Vaitkevicius H; Smallwood JA; Givertz MM; Feske SK
Stroke; 2018 May; 49(5):1197-1203. PubMed ID: 29643259
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of strokes associated with centrifugal flow left ventricular assist devices.
Inamullah O; Chiang YP; Bishawi M; Weiss M; Lutz MW; Blue LJ; Feng W; Milano CA; Luedke M; Husseini NE
Sci Rep; 2021 Jan; 11(1):1645. PubMed ID: 33462301
[TBL] [Abstract][Full Text] [Related]
6. Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: A nationwide study.
Thakkar S; Rupareliya C; Doshi R
Indian Heart J; 2019; 71(5):422-424. PubMed ID: 32035527
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Cerebral Microbleeds in Patients With Continuous-Flow Left Ventricular Assist Devices.
Yoshioka D; Okazaki S; Toda K; Murase S; Saito S; Domae K; Miyagawa S; Yoshikawa Y; Daimon T; Sakaguchi M; Sawa Y
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28893764
[TBL] [Abstract][Full Text] [Related]
9. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
Teuteberg JJ; Slaughter MS; Rogers JG; McGee EC; Pagani FD; Gordon R; Rame E; Acker M; Kormos RL; Salerno C; Schleeter TP; Goldstein DJ; Shin J; Starling RC; Wozniak T; Malik AS; Silvestry S; Ewald GA; Jorde UP; Naka Y; Birks E; Najarian KB; Hathaway DR; Aaronson KD;
JACC Heart Fail; 2015 Oct; 3(10):818-28. PubMed ID: 26450000
[TBL] [Abstract][Full Text] [Related]
10. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.
Acharya D; Loyaga-Rendon R; Morgan CJ; Sands KA; Pamboukian SV; Rajapreyar I; Holman WL; Kirklin JK; Tallaj JA
JACC Heart Fail; 2017 Oct; 5(10):703-711. PubMed ID: 28958345
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
[TBL] [Abstract][Full Text] [Related]
12. Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device.
Cho SM; Moazami N; Katz S; Bhimraj A; Shrestha NK; Frontera JA
Neurocrit Care; 2019 Aug; 31(1):72-80. PubMed ID: 30644037
[TBL] [Abstract][Full Text] [Related]
13. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
14. From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival?
Tarzia V; Di Giammarco G; Di Mauro M; Bortolussi G; Maccherini M; Tursi V; Maiani M; Bernazzali S; Marinelli D; Foschi M; Buratto E; Bejko J; Gregori D; Scuri S; Livi U; Sani G; Bottio T; Gerosa G
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):213-7. PubMed ID: 26548997
[TBL] [Abstract][Full Text] [Related]
15. Stroke Risk and Mortality in Patients With Ventricular Assist Devices.
Parikh NS; Cool J; Karas MG; Boehme AK; Kamel H
Stroke; 2016 Nov; 47(11):2702-2706. PubMed ID: 27650070
[TBL] [Abstract][Full Text] [Related]
16. The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure.
Vieira JL; Pfeffer M; Claggett BL; Stewart GC; Givertz MM; Coakley L; Mallidi HR; Mehra MR
J Heart Lung Transplant; 2020 Jun; 39(6):582-592. PubMed ID: 32220561
[TBL] [Abstract][Full Text] [Related]
17. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
18. Factors defining occurrence of ischemic and hemorrhagic strokes during continuous flow left ventricular assist device support.
Tsiouris A; Heliopoulos I; Mikroulis D; Mitsias PD
Gen Thorac Cardiovasc Surg; 2020 Apr; 68(4):319-327. PubMed ID: 31435873
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular Events After Continuous-Flow Left Ventricular Assist Devices.
Tahsili-Fahadan P; Curfman DR; Davis AA; Yahyavi-Firouz-Abadi N; Rivera-Lara L; Nassif ME; LaRue SJ; Ewald GA; Zazulia AR
Neurocrit Care; 2018 Oct; 29(2):225-232. PubMed ID: 29637518
[TBL] [Abstract][Full Text] [Related]
20. Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis.
Shah P; Birk SE; Cooper LB; Psotka MA; Kirklin JK; Barnett SD; Katugaha SB; Phillips S; Looby MM; Pagani FD; Cowger JA
J Heart Lung Transplant; 2019 Jul; 38(7):721-730. PubMed ID: 30954340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
